Data presented at European Molecular Imaging Meeting (EMIM 2025) for imaging with 68Ga-RAD202 confirms specific accumulation in the tumor, ...
Data presented at European Molecular Imaging Meeting (EMIM 2025) for imaging with 68Ga-RAD202 confirms specific accumulation in the tumor, favorable biodistribution and low uptake in non-target organs ...
Cedric Pobel, MD, covers the PEACE-1 trial of radiotherapy, standard of care, and abiraterone in low-volume metastatic castration-sensitive prostate cancer.
Researchers have found in a nonrandomised pilot trial that selumetinib showed a reduction in cutaneous neurofibromatosis ...
UPPSALA, SE / ACCESS Newswire / March 12, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B) (FRA:9II) Today, Biovica, ...
Natera offers robust growth with strong financials and innovative tests. Find out why NTRA stock is a Buy, despite potential ...
It could be that keeping a diary — “keep” being the operative word — is how we stay true to ourselves, even the embarrassing ...
Lyell Immunopharma, Inc.’s LYEL share price has dipped by 11.67%, which has investors questioning if this is right time to buy.
In a live event, Ganesh V. Raj, MD, PhD, discussed the drug-drug interactions and outcomes by disease volumes across ARPI trials in mHSPC.
The 177Lu-RAD202 drug used in conjunction with a similar imaging agent has seen some patients with breast cancer undergo a ...
4d
Achieves alignment with U.S. Food and Drug Administration (FDA) on regulatory path for potential accelerated approval of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback